Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
8.28
-0.29 (-3.38%)
Dec 20, 2024, 4:00 PM EST - Market closed
Y-mAbs Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 371 | 297 | 213 | 707 | 2,006 | 1,242 | |
| Market Cap Growth | 146.54% | 39.61% | -69.88% | -64.73% | 61.56% | 78.51% | |
| Enterprise Value | 304 | 213 | 101 | 494 | 1,879 | 1,146 | |
| Last Close Price | 8.28 | 6.82 | 4.88 | 16.21 | 49.51 | 31.25 | |
| PS Ratio | 4.31 | 3.51 | 3.27 | 20.27 | 96.67 | - | |
| PB Ratio | 4.01 | 2.95 | 1.95 | 3.93 | 18.95 | 6.24 | |
| P/TBV Ratio | 6.51 | 3.02 | 2.01 | 3.96 | 18.95 | 6.24 | |
| EV/Sales Ratio | 3.59 | 2.51 | 1.54 | 14.16 | 90.55 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.01 | |
| Asset Turnover | 0.68 | 0.63 | 0.37 | 0.20 | 0.12 | - | |
| Inventory Turnover | 1.13 | 1.94 | 1.24 | - | - | - | |
| Quick Ratio | 3.48 | 5.02 | 4.18 | 6.79 | 5.87 | 15.25 | |
| Current Ratio | 3.92 | 5.52 | 4.61 | 7.26 | 6.26 | 15.60 | |
| Return on Equity (ROE) | -24.78% | -20.39% | -66.06% | -38.66% | -78.32% | -47.74% | |
| Return on Assets (ROA) | -11.98% | -9.83% | -29.40% | -41.84% | -43.03% | -28.17% | |
| Return on Capital (ROIC) | -15.33% | -12.41% | -35.34% | -49.15% | -48.21% | -30.37% | |
| Earnings Yield | -6.43% | -7.20% | -44.85% | -7.81% | -5.95% | -6.53% | |
| FCF Yield | -5.90% | -9.15% | -35.63% | -14.59% | -4.56% | -6.08% | |
| Buyback Yield / Dilution | -0.82% | 0.13% | -1.21% | -7.64% | -14.03% | -22.28% | |
| Total Shareholder Return | -0.82% | 0.13% | -1.21% | -7.64% | -14.03% | -22.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.